10058-F4

N/A

Report date: 2022/07/28 10:42:58
NME

Base Information

Drug Name10058-F4
Drug Alias Name10058-F410058-F-4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-Myc/Max complex inhibitors
Targetsc-Myc/Max complex
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Pittsburgh
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A